Searching...Lobbying Arrangements: Health Issues
New Lobbying Registrations About Health Issues By Quarter
Former Covered Federal Workers:
Other Lobbyists:
| Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
|---|---|---|---|---|---|
| Details General healthcare issues and competition issues |
Illumina
|
Farragut Partners LLP | |||
| Details Issues related to coverage policies and pbms, general healthcare issues |
Assertio Holdings, Inc
|
Farragut Partners LLP | |||
| Details Autism coverage under the Department of Defense's TRICARE program; Issues related to access to services for those with autism spectrum disorder (ASD); HR 5116, S 2688, Behavioral Health Information... |
The Council for Autism Service Providers (CASP)
|
Gephardt Group Government Affairs | |||
| Details Healthcare reform and modernization efforts |
Medical Properties Trust
|
Cassidy & Associates, Inc. | |||
| Details General issues related to clinical laboratories and reimbursement for clinical laboratory services. Issues related S.1000/H.R.2377, Saving Access to Laboratory Services Act. Issues related to cod... |
American Clinical Laboratory Association
|
Kountoupes Denham Carr & Reid, LLC | |||
| Details Covid policies |
Enanta Pharmaceuticals
|
Slaiman Consulting LLC | |||
| Details Lobbying related to innovation and competition in the life sciences sector |
Weil, Gotshal & Manges LLP (On behalf of NanoString Technologies, Inc.)
|
FGS Global (US) LLC (FKA FGH Holdings LLC) | |||
| Details H.R. 830/S. 1375, HELP Copays Act H.R. 2673, American Innovation and R&D Competitiveness Act of 2023 H.R. 2630/S. 652, Safe Step Act S. 866, American Innovation and Jobs Act S. 1906 Promising Pathw... |
Astria Therapeutics, Inc.
|
THE KPM GROUP DC LLC | |||
| Details CMS, insurance, healthcare, clinical labs |
PATHOLOGY AND CYTOLOGY LABORATORIES, INC.
|
GABBERT CONSULTING CO LLC | |||
| Details Issues related to autism therapy. |
Gephardt Group Government Affairs on behalf of Forta
|
The O Team LLC | |||
| Details Cognitive Therapy innovations Use of Cognitive Therapy in Physical Therapy |
Academy MedTech Ventures
|
MODERN FORTIS LLC | |||
| Details Regulation of CBD |
XXII Century Group
|
ALPINE GROUP PARTNERS, LLC. | |||
| Details Red Bull's Glendale, Arizona facility is located in a Foreign Trade Zone, and the business is seeking Weekly Entry Filing permission from FDA. |
Red Bull North America, Inc.
|
in-house lobbying | |||
| Details Advocate on federal policy change regarding the publication of federally funded research. |
Wolters Kluwer Health
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
| Details Issues related to Medicare coverage and reimbursement and Medicaid coverage and reimbursement |
University of Colorado Health
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
| Details Scalability of regenerative medicine technology |
Cellino Biotech Inc.
|
iPolicy Solutions | |||
| Details H.R. 5074, The Kidney Patient Act of 2023; H.R. 2407, The Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act; S. 2085, The Medicare Multi-Cancer Early Detection Scree... |
National Minority Quality Forum Action Network
|
Integrated Solutions Group | |||
| Details The Access to AEDs Act, and legislative proposals that align with the associations mission of building healthier lives, free of cardiovascular diseases and stroke. |
American Heart Association
|
alb solutions | |||
| Details Issues related to legislative and regulatory advocacy on Medicare, Medicaid and hospital related issues - no specific legislation. H.R. 5378 - The Lower Costs More Transparency Act - issues impacti... |
Virginia Hospital and Healthcare Association
|
K&L GATES LLP | |||
| Details H.R.4818 / S.2407 - Treat and Reduce Obesity Act (TROA) of 2023. |
Gerontological Society of America
|
NVG, LLC | |||
| Details FY24 Appropriations |
Humanetics Corporation
|
HARPER DOWNING | |||
| Details Issues related to access to autism services |
Forta
|
Gephardt Group Government Affairs | |||
| Details Educating Members of Congress regarding behavioral and mental health policy issues and access to resources in communities |
Trilogy Integrated Resources
|
THE VOGEL GROUP | |||
| Details language to expand TMS therapy reimbursement to general practitioners |
Neuronetics Inc.
|
THE VOGEL GROUP | |||
| Details issues related to Valley Fever and fungal vaccines |
Anivive Lifesciences
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
| Details Issues related to combination product development |
Aurion Biotech
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
| Details Issues related to apheresis access and reimbursement Issues related to supply chain constraints |
TERUMO BCT
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
| Details H.R. 2670 National Defense Authorization Act for Fiscal year 2024 H.Amdt. 257 |
Complete Genomics
|
THE VOGEL GROUP | |||
| Details Issues related to site neutral payments |
Alliance of Dedicated Cancer Centers
|
The Duberstein Group Inc. | |||
| Details Lobbying related to Congressional and Administration introductions and company updates. |
WuXi Biologics USA LLC
|
FGS Global (US) LLC (FKA FGH Holdings LLC) |